{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:44:52Z","timestamp":1794545092119,"version":"4.9.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Methadone is often used in pediatric patients to prevent or treat opioid withdrawal after prolonged sedation. Prolonged corrected QT interval is an important adverse effect of methadone because it can progress to torsades de pointes, a potentially fatal dysrhythmia. The prevalence of corrected QT interval prolongation and contributing risk factors are not well defined in hospitalized pediatric patients receiving methadone. The study purpose was to identify the frequency and risk factors of corrected QT interval prolongation in hospitalized pediatric patients receiving methadone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Tertiary academic pediatric hospital, University of California Davis Children\u2019s Hospital, Sacramento, CA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Cohort of 89 pediatric patients (birth to 18 yr) who received at least one dose of methadone while hospitalized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Retrospective data over 7.5 years were obtained from the electronic health record.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>From the cohort, 45 patients (50.6%) had documented corrected QT interval prolongation (\u2265 450\u2009ms) during the study period. No episodes of torsades de pointes were identified. In univariate analyses, higher maximum methadone doses were associated with a prolonged corrected QT interval (0.98 vs 0.59\u2009mg\/kg\/d; odds ratio, 2.56; 1.15\u20135.70). Corrected QT interval prolongation occurred more frequently in patients with cardiac disease (63% vs 41%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.10). No factors were statistically significant in the multivariate analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In hospitalized pediatric patients receiving methadone, corrected QT interval prolongation was common, but no episodes of torsades de pointes were documented. Risk factors that have been identified in adults were not associated with prolongation in our study population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001601","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T17:09:34Z","timestamp":1528823374000},"page":"e403-e408","source":"Crossref","is-referenced-by-count":11,"title":["Corrected QT Interval Prolongation in Hospitalized Pediatric Patients Receiving Methadone"],"prefix":"10.1097","volume":"19","author":[{"given":"Amy J.","family":"Schwinghammer","sequence":"first","affiliation":[{"name":"Department of Pharmacy Services, University of California, Davis Health, Sacramento, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machelle D.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Public Health Services, Division of Biostatistics, Clinical and Translational Science Center, University of California, Sacramento, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, University of California, Davis Health, Sacramento, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1542\/peds.2009-0489","article-title":"Tolerance and withdrawal from prolonged opioid use in critically ill children.","volume":"125","author":"Anand","year":"2010","journal-title":"Pediatrics"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","article-title":"Methadone safety: A clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.","volume":"15","author":"Chou","year":"2014","journal-title":"J Pain"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2146\/ajhp070392","article-title":"Methadone-associated Q-T interval prolongation and torsades de pointes.","volume":"66","author":"Stringer","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5055\/jom.2013.0167","article-title":"Prolonged QT interval by methadone: Relevance for daily practice? A prospective study in patients with cancer and noncancer pain.","volume":"9","author":"van den Beuken-van Everdingen","year":"2013","journal-title":"J Opioid Manag"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.drugalcdep.2008.06.018","article-title":"Prevalence of long QTc interval in methadone maintenance patients.","volume":"99","author":"Fonseca","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1360-0443.2011.03767.x","article-title":"Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.","volume":"107","author":"Roy","year":"2012","journal-title":"Addiction"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: High frequency in hospitalized patients and risk factors.","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5055\/jom.2016.0325","article-title":"Methadone prolongs cardiac conduction in young patients with cancer-related pain.","volume":"12","author":"Anghelescu","year":"2016","journal-title":"J Opioid Manag"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: Reports to the FDA spontaneous reporting system.","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","article-title":"Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.","volume":"23","author":"Krantz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2006.01512.x","article-title":"Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients.","volume":"101","author":"Justo","year":"2006","journal-title":"Addiction"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpainsymman.2013.09.021","article-title":"Methadone for pain and the risk of adverse cardiac outcomes.","volume":"48","author":"Price","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7326\/0003-4819-139-2-200307150-00021","article-title":"The impact of methadone induction on cardiac conduction in opiate users.","volume":"139","author":"Martell","year":"2003","journal-title":"Ann Intern Med"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents.","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pan.13056","article-title":"The use of methadone to facilitate opioid weaning in pediatric critical care patients: A systematic review of the literature and meta-analysis.","volume":"27","author":"Dervan","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.1.6057.375","article-title":"Methadone: Evidence of accumulation.","volume":"1","author":"Leslie","year":"1977","journal-title":"Br Med J"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201808000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:42:44Z","timestamp":1692837764000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201808000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001601","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}